National Advisory Council Chairperson Sonia Gandhi today voiced concern over the high dropout rate and the absence of teachers in village schools. She noted that "one fourth of the teachers" in village schools remain absent and said the dropout rate, particularly amongst the minority and poor, was high. Speaking at a function after inaugurating 31 Navodaya Vidyalayas in various parts of the country, Gandhi said, "Everyone has a right to education and...

The must debated Right to Education (RTE) Act has raised several questions with regards to its overall impact on the education system in the country. In order to put the Act in the right perspective so that all the stakeholders — schools, teachers, families, parents, children, and civil society —understand its provisions better, the United Nations Children’s Fund (Unicef) and Sarva Shiksha Abhiyan (SSA), Karnataka, will jointly start a campaign withfocus...

Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...

Television and print media have been awash with pictures of stacks of sacks of rotting foodgrain. And played in an almost infinite loop, these pictures become obviously powerful. They can become a call to urgent and revolutionary action. This perhaps accounts for the emotive appeal of the Supreme Court’s recent intervention on distributing this grain, and to keep procurement commensurate with available storage facilities. It does not, however, explain the...

No clarity on which authorities will be competent or which laws will be relevant: Ramesh He agrees with the compromise of Department of S&T as the nodal Ministry The Biotechnology Regulatory Authority of India (BRAI) will only deal with the safety and efficacy aspects of biotech products, leaving the controversial commercialisation aspect hanging in the air, according to the latest version of the BRAI Bill, 2010. The Bill, which was supposed to be...